路径ID,路径描述,间接效应均值,间接效应HDI下限,间接效应HDI上限,间接效应标准差,直接效应均值,直接效应HDI下限,直接效应HDI上限,直接效应标准差,总效应均值,总效应HDI下限,总效应HDI上限,总效应标准差,中介比例,中介比例百分比,主要影响类型,影响强度,间接效应方向,直接效应方向,中介类型,显著性概率,是否显著,正向效应概率,负向效应概率,结论
1,疾病_反流性食管炎 → 疾病_糖尿病 → 疾病_高尿酸血症,-0.1322,-0.2699,-0.0062,0.0735,-0.0463,-0.3008,0.216,0.1388,-0.1786,-0.4406,0.1098,0.1473,1.6219,162.2,间接影响（中介效应）,强,负向中介,负向直接效应,完全中介,0.987,是,0.013,0.987,该路径存在显著的负向中介，主要通过间接影响发挥作用。 中介效应强度为完全中介，中介比例为162.2%。
2,疾病_反流性食管炎 → 疾病_糖尿病 → 药物_盐酸羟考酮缓释片,-0.0976,-0.2169,0.0165,0.0655,-0.0038,-0.2982,0.2696,0.1526,-0.1014,-0.3965,0.1936,0.1555,2.8479,284.8,间接影响（中介效应）,强,负向中介,负向直接效应,完全中介,0.9725,是,0.0275,0.9725,该路径存在显著的负向中介，主要通过间接影响发挥作用。 中介效应强度为完全中介，中介比例为284.8%。
3,疾病_反流性食管炎 → 疾病_糖尿病 → 药物_阿卡波糖片,-0.1436,-0.2877,-0.0195,0.0764,-0.0004,-0.2425,0.2731,0.137,-0.144,-0.4397,0.1096,0.1466,1.2574,125.7,间接影响（中介效应）,强,负向中介,负向直接效应,完全中介,0.9895,是,0.0105,0.9895,该路径存在显著的负向中介，主要通过间接影响发挥作用。 中介效应强度为完全中介，中介比例为125.7%。
4,疾病_反流性食管炎 → 疾病_糖尿病 → 药物_阿司匹林肠溶片,-0.167,-0.3233,-0.0171,0.0843,0.1117,-0.148,0.3671,0.1371,-0.0554,-0.3516,0.206,0.1489,7.9635,796.3,间接影响（中介效应）,强,负向中介,正向直接效应,完全中介,0.987,是,0.013,0.987,该路径存在显著的负向中介，主要通过间接影响发挥作用。 中介效应强度为完全中介，中介比例为796.3%。
5,疾病_反流性食管炎 → 疾病_糖尿病 → 检验_葡萄糖,-0.1707,-0.3451,-0.0302,0.0866,0.1928,-0.0624,0.447,0.1372,0.0221,-0.2666,0.2873,0.1507,78.1774,7817.7,直接影响,强,负向中介,正向直接效应,完全中介,0.9845,是,0.0155,0.9845,该路径存在显著的正向直接效应，主要通过直接影响发挥作用。 中介效应强度为完全中介，中介比例为7817.7%。
6,疾病_反流性食管炎 → 药物_氯化钠注射液 → 检验_谷草/谷丙,-0.0172,-0.0875,0.0382,0.0328,-0.0627,-0.3528,0.2034,0.1461,-0.0798,-0.3553,0.1901,0.1448,0.344,34.4,直接影响,强,负向中介,负向直接效应,部分中介,0.7035,否,0.2965,0.7035,该路径的中介效应不显著。 中介效应强度为部分中介，中介比例为34.4%。
7,疾病_反流性食管炎 → 药物_氯化钠注射液 → 药物_肝素钠注射液,0.0725,-0.0351,0.2154,0.0667,-0.1437,-0.4023,0.0937,0.133,-0.0712,-0.3472,0.188,0.1446,-1.4812,-148.1,直接影响,强,正向中介,负向直接效应,完全中介,0.8935,否,0.8935,0.1065,该路径的中介效应不显著。 中介效应强度为完全中介，中介比例为-148.1%。
8,疾病_高血压 → 检验_总蛋白 → 疾病_动脉硬化,0.0098,-0.13,0.1413,0.07,0.1166,-0.1737,0.4357,0.1618,0.1264,-0.1591,0.3953,0.1475,0.212,21.2,直接影响,强,正向中介,正向直接效应,部分中介,0.548,否,0.548,0.452,该路径的中介效应不显著。 中介效应强度为部分中介，中介比例为21.2%。
9,疾病_高血压 → 检验_总蛋白 → 药物_苯磺酸氨氯地平片,0.0968,-0.022,0.2464,0.0711,0.1722,-0.1094,0.4687,0.156,0.269,-0.017,0.5188,0.1445,0.5744,57.4,直接影响,强,正向中介,正向直接效应,部分中介,0.9375,否,0.9375,0.0625,该路径的中介效应不显著。 中介效应强度为部分中介，中介比例为57.4%。
10,疾病_高血压 → 检验_总蛋白 → 检验_氯,0.146,0.0058,0.3018,0.0824,-0.132,-0.4183,0.1581,0.1533,0.014,-0.2727,0.2643,0.1449,-1.0873,-108.7,间接影响（中介效应）,强,正向中介,负向直接效应,完全中介,0.9875,是,0.9875,0.0125,该路径存在显著的正向中介，主要通过间接影响发挥作用。 中介效应强度为完全中介，中介比例为-108.7%。
11,疾病_高血压 → 药物_阿司匹林肠溶片 → 疾病_糖尿病,0.0271,-0.1204,0.16,0.0741,0.0597,-0.1847,0.3084,0.1296,0.0868,-0.2018,0.3511,0.1459,0.759,75.9,直接影响,强,正向中介,正向直接效应,部分中介,0.639,否,0.639,0.361,该路径的中介效应不显著。 中介效应强度为部分中介，中介比例为75.9%。
12,疾病_高血压 → 检验_碳酸氢盐 → 检验_总蛋白,-0.0401,-0.1272,0.0227,0.042,0.4504,0.1907,0.7237,0.1401,0.4103,0.1438,0.6643,0.1409,-0.112,-11.2,直接影响,强,负向中介,正向直接效应,弱中介,0.8815,否,0.1185,0.8815,该路径的中介效应不显著。 中介效应强度为弱中介，中介比例为-11.2%。
13,疾病_高血压 → 检验_碳酸氢盐 → 检验_尿酸,0.0776,-0.0312,0.2052,0.0647,-0.085,-0.3496,0.1806,0.1433,-0.0075,-0.2793,0.2681,0.1485,0.7123,71.2,直接影响,强,正向中介,负向直接效应,部分中介,0.9325,否,0.9325,0.0675,该路径的中介效应不显著。 中介效应强度为部分中介，中介比例为71.2%。
14,疾病_高血压 → 检验_碳酸氢盐 → 检验_磷,-0.0236,-0.1075,0.0407,0.0389,-0.1658,-0.4494,0.1235,0.1516,-0.1894,-0.4638,0.0965,0.15,-0.0307,-3.1,直接影响,强,负向中介,负向直接效应,弱中介,0.7525,否,0.2475,0.7525,该路径的中介效应不显著。 中介效应强度为弱中介，中介比例为-3.1%。
15,疾病_高血压 → 药物_阿卡波糖片 → 疾病_冠状动脉粥样硬化性心脏病,0.0363,-0.0784,0.1668,0.0652,0.1275,-0.1556,0.4514,0.1595,0.1638,-0.1132,0.453,0.1496,-2.0685,-206.8,直接影响,强,正向中介,正向直接效应,完全中介,0.713,否,0.713,0.287,该路径的中介效应不显著。 中介效应强度为完全中介，中介比例为-206.8%。
16,检验_尿酸 → 检验_碳酸氢盐 → 检验_总蛋白,-0.0455,-0.1638,0.0559,0.0581,0.1221,-0.1898,0.402,0.1555,0.0766,-0.2118,0.344,0.1495,-0.1186,-11.9,直接影响,强,负向中介,正向直接效应,弱中介,0.8125,否,0.1875,0.8125,该路径的中介效应不显著。 中介效应强度为弱中介，中介比例为-11.9%。
17,检验_尿酸 → 检验_碳酸氢盐 → 检验_磷,-0.1001,-0.2212,0.0126,0.0652,0.4477,0.1614,0.7055,0.1455,0.3476,0.0684,0.6026,0.141,-0.3789,-37.9,直接影响,强,负向中介,正向直接效应,部分中介,0.976,是,0.024,0.976,该路径存在显著的正向直接效应，主要通过直接影响发挥作用。 中介效应强度为部分中介，中介比例为-37.9%。
18,检验_尿酸 → 检验_磷 → 药物_碳酸钙片,0.1367,0.0091,0.2866,0.0761,-0.0692,-0.3705,0.1802,0.1441,0.0676,-0.2194,0.3332,0.1453,1.5754,157.5,间接影响（中介效应）,强,正向中介,负向直接效应,完全中介,0.9905,是,0.9905,0.0095,该路径存在显著的正向中介，主要通过间接影响发挥作用。 中介效应强度为完全中介，中介比例为157.5%。
19,检验_尿酸 → 药物_硫酸氢氯吡格雷片 → 药物_苯磺酸氨氯地平片,0.1351,0.0081,0.291,0.0776,-0.0696,-0.3123,0.1834,0.1353,0.0655,-0.1978,0.3384,0.145,0.1045,10.4,间接影响（中介效应）,强,正向中介,负向直接效应,弱中介,0.981,是,0.981,0.019,该路径存在显著的正向中介，主要通过间接影响发挥作用。 中介效应强度为弱中介，中介比例为10.4%。
20,检验_尿酸 → 疾病_混合痔 → 疾病_高脂血症,0.1398,0.0078,0.2887,0.0784,0.0329,-0.2552,0.3185,0.1528,0.1728,-0.1429,0.438,0.1529,0.9277,92.8,间接影响（中介效应）,强,正向中介,正向直接效应,完全中介,0.99,是,0.99,0.01,该路径存在显著的正向中介，主要通过间接影响发挥作用。 中介效应强度为完全中介，中介比例为92.8%。
21,检验_尿酸 → 疾病_混合痔 → 检验_葡萄糖,0.1233,-0.0028,0.263,0.0747,0.0847,-0.1868,0.3632,0.1453,0.2079,-0.0571,0.4885,0.1454,7.7348,773.5,间接影响（中介效应）,强,正向中介,正向直接效应,完全中介,0.982,是,0.982,0.018,该路径存在显著的正向中介，主要通过间接影响发挥作用。 中介效应强度为完全中介，中介比例为773.5%。
22,疾病_糖尿病 → 疾病_高尿酸血症 → 疾病_脂肪肝,-0.014,-0.1666,0.1267,0.0765,0.1928,-0.143,0.4746,0.1632,0.1788,-0.0867,0.4441,0.1435,-0.0769,-7.7,直接影响,强,负向中介,正向直接效应,弱中介,0.5795,否,0.4205,0.5795,该路径的中介效应不显著。 中介效应强度为弱中介，中介比例为-7.7%。
23,疾病_糖尿病 → 药物_阿卡波糖片 → 疾病_高血压,0.206,0.0409,0.3937,0.0956,-0.1182,-0.4198,0.1423,0.1517,0.0878,-0.1822,0.3668,0.1472,4.4679,446.8,间接影响（中介效应）,强,正向中介,负向直接效应,完全中介,0.9965,是,0.9965,0.0035,该路径存在显著的正向中介，主要通过间接影响发挥作用。 中介效应强度为完全中介，中介比例为446.8%。
24,疾病_糖尿病 → 药物_阿卡波糖片 → 疾病_冠状动脉粥样硬化性心脏病,0.1015,-0.0604,0.2522,0.0828,-0.1597,-0.4618,0.1446,0.1612,-0.0582,-0.3201,0.2236,0.1453,-3.5015,-350.2,直接影响,强,正向中介,负向直接效应,完全中介,0.9115,否,0.9115,0.0885,该路径的中介效应不显著。 中介效应强度为完全中介，中介比例为-350.2%。
25,疾病_糖尿病 → 检验_葡萄糖 → 疾病_混合痔,-0.1537,-0.3413,-0.0084,0.0874,-0.0848,-0.3682,0.2444,0.1616,-0.2385,-0.5153,0.0306,0.1453,0.2484,24.8,间接影响（中介效应）,强,负向中介,负向直接效应,部分中介,0.974,是,0.026,0.974,该路径存在显著的负向中介，主要通过间接影响发挥作用。 中介效应强度为部分中介，中介比例为24.8%。
26,疾病_糖尿病 → 检验_葡萄糖 → 疾病_冠状动脉粥样硬化性心脏病,-0.1106,-0.2873,0.0438,0.0875,0.0509,-0.2454,0.3514,0.161,-0.0596,-0.3509,0.1896,0.1451,0.9079,90.8,间接影响（中介效应）,强,负向中介,正向直接效应,完全中介,0.912,否,0.088,0.912,该路径的中介效应不显著。 中介效应强度为完全中介，中介比例为90.8%。
27,检验_谷草/谷丙 → 疾病_糖尿病 → 疾病_高尿酸血症,-0.0893,-0.2295,0.0346,0.0719,0.154,-0.0999,0.4345,0.1398,0.0647,-0.2279,0.3579,0.1525,-3.4834,-348.3,直接影响,强,负向中介,正向直接效应,完全中介,0.9245,否,0.0755,0.9245,该路径的中介效应不显著。 中介效应强度为完全中介，中介比例为-348.3%。
28,检验_谷草/谷丙 → 疾病_糖尿病 → 药物_盐酸羟考酮缓释片,-0.0533,-0.1536,0.0265,0.0503,-0.1788,-0.455,0.0713,0.1402,-0.2321,-0.5142,0.0329,0.1454,0.2064,20.6,直接影响,强,负向中介,负向直接效应,部分中介,0.8985,否,0.1015,0.8985,该路径的中介效应不显著。 中介效应强度为部分中介，中介比例为20.6%。
29,检验_谷草/谷丙 → 疾病_糖尿病 → 药物_阿卡波糖片,-0.0883,-0.2269,0.042,0.0733,0.0433,-0.2497,0.2949,0.1434,-0.0451,-0.3617,0.2274,0.1568,1.6592,165.9,间接影响（中介效应）,强,负向中介,正向直接效应,完全中介,0.905,否,0.095,0.905,该路径的中介效应不显著。 中介效应强度为完全中介，中介比例为165.9%。
30,检验_谷草/谷丙 → 疾病_糖尿病 → 药物_阿司匹林肠溶片,-0.1062,-0.263,0.0648,0.0871,0.3323,0.0928,0.5519,0.1231,0.2262,-0.0527,0.4959,0.1466,-0.6309,-63.1,直接影响,强,负向中介,正向直接效应,部分中介,0.902,否,0.098,0.902,该路径的中介效应不显著。 中介效应强度为部分中介，中介比例为-63.1%。
31,检验_谷草/谷丙 → 疾病_糖尿病 → 检验_葡萄糖,-0.0972,-0.2532,0.0482,0.0798,0.1818,-0.0691,0.4236,0.1301,0.0846,-0.1793,0.3882,0.1495,-1.1694,-116.9,直接影响,强,负向中介,正向直接效应,完全中介,0.912,否,0.088,0.912,该路径的中介效应不显著。 中介效应强度为完全中介，中介比例为-116.9%。
32,检验_谷草/谷丙 → 药物_硫酸氢氯吡格雷片 → 药物_苯磺酸氨氯地平片,-0.1012,-0.2509,0.006,0.0699,-0.1321,-0.3676,0.1255,0.1304,-0.2334,-0.5021,0.021,0.1383,-1.117,-111.7,直接影响,强,负向中介,负向直接效应,完全中介,0.9575,是,0.0425,0.9575,该路径存在显著的负向直接效应，主要通过直接影响发挥作用。 中介效应强度为完全中介，中介比例为-111.7%。
33,疾病_高脂血症 → 疾病_反流性食管炎 → 药物_艾司唑仑片,0.1582,0.0008,0.3059,0.0824,0.1313,-0.1449,0.4164,0.1469,0.2895,0.0251,0.5579,0.1405,0.8139,81.4,间接影响（中介效应）,强,正向中介,正向直接效应,完全中介,0.991,是,0.991,0.009,该路径存在显著的正向中介，主要通过间接影响发挥作用。 中介效应强度为完全中介，中介比例为81.4%。
34,疾病_高脂血症 → 疾病_反流性食管炎 → 疾病_糖尿病,-0.1579,-0.3256,-0.0136,0.084,0.1363,-0.1291,0.4542,0.154,-0.0217,-0.3069,0.2442,0.1455,0.4577,45.8,间接影响（中介效应）,强,负向中介,正向直接效应,部分中介,0.9835,是,0.0165,0.9835,该路径存在显著的负向中介，主要通过间接影响发挥作用。 中介效应强度为部分中介，中介比例为45.8%。
35,疾病_高脂血症 → 疾病_反流性食管炎 → 药物_氯化钠注射液,0.1025,-0.0382,0.2399,0.0763,-0.175,-0.4781,0.1114,0.1559,-0.0725,-0.3406,0.2041,0.1462,3.1748,317.5,直接影响,强,正向中介,负向直接效应,完全中介,0.9335,否,0.9335,0.0665,该路径的中介效应不显著。 中介效应强度为完全中介，中介比例为317.5%。
36,疾病_高脂血症 → 药物_阿托伐他汀钙片 → 疾病_高尿酸血症,0.1191,-0.0302,0.2978,0.0886,-0.0944,-0.43,0.2054,0.1671,0.0247,-0.2692,0.3118,0.1548,0.3984,39.8,间接影响（中介效应）,强,正向中介,负向直接效应,部分中介,0.9355,否,0.9355,0.0645,该路径的中介效应不显著。 中介效应强度为部分中介，中介比例为39.8%。
37,疾病_高脂血症 → 疾病_动脉硬化 → 疾病_脂肪肝,0.1946,0.0445,0.3543,0.0853,0.1001,-0.194,0.3574,0.1458,0.2947,0.0282,0.5691,0.1431,0.5166,51.7,间接影响（中介效应）,强,正向中介,正向直接效应,部分中介,0.997,是,0.997,0.003,该路径存在显著的正向中介，主要通过间接影响发挥作用。 中介效应强度为部分中介，中介比例为51.7%。
38,疾病_高脂血症 → 疾病_混合痔 → 检验_尿酸,0.1436,0.0109,0.2917,0.0781,0.0325,-0.2449,0.3057,0.1477,0.176,-0.1108,0.4508,0.1495,0.2153,21.5,间接影响（中介效应）,强,正向中介,正向直接效应,部分中介,0.991,是,0.991,0.009,该路径存在显著的正向中介，主要通过间接影响发挥作用。 中介效应强度为部分中介，中介比例为21.5%。
39,疾病_高脂血症 → 疾病_混合痔 → 检验_葡萄糖,0.1168,-0.0108,0.2428,0.0717,0.0548,-0.2267,0.3328,0.1503,0.1716,-0.1017,0.4482,0.1506,2.1322,213.2,间接影响（中介效应）,强,正向中介,正向直接效应,完全中介,0.98,是,0.98,0.02,该路径存在显著的正向中介，主要通过间接影响发挥作用。 中介效应强度为完全中介，中介比例为213.2%。
40,疾病_高脂血症 → 药物_阿司匹林肠溶片 → 疾病_糖尿病,0.127,-0.0145,0.2908,0.0829,-0.1481,-0.3923,0.0893,0.127,-0.0211,-0.2888,0.2356,0.1424,0.5478,54.8,直接影响,强,正向中介,负向直接效应,部分中介,0.956,是,0.956,0.044,该路径存在显著的负向直接效应，主要通过直接影响发挥作用。 中介效应强度为部分中介，中介比例为54.8%。
41,药物_阿托伐他汀钙片 → 疾病_高脂血症 → 疾病_反流性食管炎,0.1994,0.0352,0.3814,0.0928,0.035,-0.2403,0.3329,0.1507,0.2343,-0.0253,0.4942,0.1403,2.1221,212.2,间接影响（中介效应）,强,正向中介,正向直接效应,完全中介,0.997,是,0.997,0.003,该路径存在显著的正向中介，主要通过间接影响发挥作用。 中介效应强度为完全中介，中介比例为212.2%。
42,药物_阿托伐他汀钙片 → 疾病_高脂血症 → 疾病_动脉硬化,0.1752,0.0117,0.3303,0.0875,0.1183,-0.1958,0.3972,0.1557,0.2935,0.0301,0.5687,0.1425,0.6535,65.4,间接影响（中介效应）,强,正向中介,正向直接效应,部分中介,0.991,是,0.991,0.009,该路径存在显著的正向中介，主要通过间接影响发挥作用。 中介效应强度为部分中介，中介比例为65.4%。
43,药物_阿托伐他汀钙片 → 疾病_高脂血症 → 疾病_混合痔,-0.1614,-0.3243,0.0034,0.0885,-0.0635,-0.3356,0.2395,0.1547,-0.2248,-0.4867,0.0459,0.1417,0.4863,48.6,间接影响（中介效应）,强,负向中介,负向直接效应,部分中介,0.9825,是,0.0175,0.9825,该路径存在显著的负向中介，主要通过间接影响发挥作用。 中介效应强度为部分中介，中介比例为48.6%。
44,药物_阿托伐他汀钙片 → 疾病_高脂血症 → 药物_阿司匹林肠溶片,0.0939,-0.0587,0.2629,0.0863,0.0772,-0.2219,0.3929,0.1625,0.1711,-0.0894,0.4299,0.1408,1.554,155.4,间接影响（中介效应）,强,正向中介,正向直接效应,完全中介,0.8875,否,0.8875,0.1125,该路径的中介效应不显著。 中介效应强度为完全中介，中介比例为155.4%。
45,药物_阿托伐他汀钙片 → 疾病_高尿酸血症 → 疾病_脂肪肝,0.011,-0.0541,0.084,0.0363,0.0155,-0.2656,0.3203,0.1546,0.0264,-0.2484,0.3227,0.1524,-0.0193,-1.9,直接影响,强,正向中介,正向直接效应,弱中介,0.622,否,0.622,0.378,该路径的中介效应不显著。 中介效应强度为弱中介，中介比例为-1.9%。
46,检验_钠 → 疾病_高脂血症 → 疾病_反流性食管炎,0.0759,-0.0315,0.2077,0.065,0.1103,-0.1664,0.3539,0.1359,0.1863,-0.0885,0.4497,0.1447,0.3084,30.8,直接影响,强,正向中介,正向直接效应,部分中介,0.913,否,0.913,0.087,该路径的中介效应不显著。 中介效应强度为部分中介，中介比例为30.8%。
47,检验_钠 → 疾病_高脂血症 → 药物_阿托伐他汀钙片,0.0943,-0.0379,0.2472,0.0762,-0.1107,-0.3718,0.1312,0.1345,-0.0165,-0.3221,0.2466,0.1493,-7.901,-790.1,直接影响,强,正向中介,负向直接效应,完全中介,0.915,否,0.915,0.085,该路径的中介效应不显著。 中介效应强度为完全中介，中介比例为-790.1%。
48,检验_钠 → 疾病_高脂血症 → 疾病_动脉硬化,0.0878,-0.0401,0.2263,0.0731,-0.2718,-0.5271,-0.0209,0.1323,-0.184,-0.4371,0.1009,0.1441,-0.2006,-20.1,直接影响,强,正向中介,负向直接效应,部分中介,0.914,否,0.914,0.086,该路径的中介效应不显著。 中介效应强度为部分中介，中介比例为-20.1%。
49,检验_钠 → 疾病_高脂血症 → 疾病_混合痔,-0.061,-0.1717,0.0293,0.0562,-0.1751,-0.4412,0.0697,0.136,-0.2361,-0.5158,0.0159,0.1431,-2.9513,-295.1,直接影响,强,负向中介,负向直接效应,完全中介,0.888,否,0.112,0.888,该路径的中介效应不显著。 中介效应强度为完全中介，中介比例为-295.1%。
50,检验_钠 → 疾病_高脂血症 → 药物_阿司匹林肠溶片,0.0345,-0.0302,0.1213,0.0422,0.2546,0.0041,0.5324,0.1437,0.2892,0.0227,0.5527,0.1443,0.1375,13.8,直接影响,强,正向中介,正向直接效应,弱中介,0.8315,否,0.8315,0.1685,该路径的中介效应不显著。 中介效应强度为弱中介，中介比例为13.8%。
51,检验_钠 → 检验_氯 → 检验_葡萄糖,-0.0878,-0.2244,0.0388,0.0717,0.1754,-0.117,0.475,0.1582,0.0876,-0.1717,0.3909,0.1494,-3.625,-362.5,直接影响,强,负向中介,正向直接效应,完全中介,0.923,否,0.077,0.923,该路径的中介效应不显著。 中介效应强度为完全中介，中介比例为-362.5%。
52,检验_钠 → 检验_氯 → 药物_肝素钠注射液,0.1648,0.0179,0.3118,0.0818,-0.224,-0.4875,0.076,0.1476,-0.0593,-0.3401,0.2104,0.1458,-0.1127,-11.3,直接影响,强,正向中介,负向直接效应,弱中介,0.994,是,0.994,0.006,该路径存在显著的负向直接效应，主要通过直接影响发挥作用。 中介效应强度为弱中介，中介比例为-11.3%。
53,检验_钠 → 药物_阿司匹林肠溶片 → 疾病_糖尿病,0.1537,0.0052,0.3168,0.0859,-0.06,-0.2984,0.1844,0.1307,0.0937,-0.1876,0.3609,0.1458,1.5118,151.2,间接影响（中介效应）,强,正向中介,负向直接效应,完全中介,0.9825,是,0.9825,0.0175,该路径存在显著的正向中介，主要通过间接影响发挥作用。 中介效应强度为完全中介，中介比例为151.2%。
54,检验_钠 → 检验_谷草/谷丙 → 检验_钾,0.0642,-0.0153,0.1738,0.053,-0.1693,-0.4355,0.1018,0.1452,-0.105,-0.3802,0.1551,0.1445,-0.1737,-17.4,直接影响,强,正向中介,负向直接效应,弱中介,0.931,否,0.931,0.069,该路径的中介效应不显著。 中介效应强度为弱中介，中介比例为-17.4%。
55,检验_钠 → 检验_谷草/谷丙 → 药物_艾司唑仑片,0.0172,-0.0679,0.1175,0.0465,-0.0065,-0.3032,0.283,0.1578,0.0107,-0.2722,0.3002,0.1534,-0.4933,-49.3,间接影响（中介效应）,强,正向中介,负向直接效应,部分中介,0.6525,否,0.6525,0.3475,该路径的中介效应不显著。 中介效应强度为部分中介，中介比例为-49.3%。
56,检验_钠 → 检验_谷草/谷丙 → 疾病_糖尿病,-0.0574,-0.1544,0.024,0.0513,0.1478,-0.1502,0.4169,0.1528,0.0903,-0.1799,0.3762,0.1512,-0.5301,-53.0,直接影响,强,负向中介,正向直接效应,部分中介,0.919,否,0.081,0.919,该路径的中介效应不显著。 中介效应强度为部分中介，中介比例为-53.0%。
57,检验_钠 → 检验_谷草/谷丙 → 药物_硫酸氢氯吡格雷片,-0.0604,-0.1617,0.0224,0.0535,-0.031,-0.3014,0.2553,0.1479,-0.0915,-0.3924,0.1727,0.1486,-12.3955,-1239.6,间接影响（中介效应）,强,负向中介,负向直接效应,完全中介,0.9225,否,0.0775,0.9225,该路径的中介效应不显著。 中介效应强度为完全中介，中介比例为-1239.6%。
58,检验_氯 → 检验_钠 → 疾病_高脂血症,0.0552,-0.0673,0.186,0.0664,0.1306,-0.1812,0.4036,0.1522,0.1858,-0.0697,0.4576,0.1409,-0.9203,-92.0,直接影响,强,正向中介,正向直接效应,完全中介,0.834,否,0.834,0.166,该路径的中介效应不显著。 中介效应强度为完全中介，中介比例为-92.0%。
59,检验_氯 → 检验_钠 → 药物_阿司匹林肠溶片,0.1386,0.0088,0.2888,0.0773,-0.158,-0.4353,0.1354,0.1538,-0.0194,-0.2809,0.2879,0.1477,-0.9026,-90.3,直接影响,强,正向中介,负向直接效应,完全中介,0.9845,是,0.9845,0.0155,该路径存在显著的负向直接效应，主要通过直接影响发挥作用。 中介效应强度为完全中介，中介比例为-90.3%。
60,检验_氯 → 检验_钠 → 检验_谷草/谷丙,0.0938,-0.0251,0.2454,0.0732,0.0559,-0.2359,0.3477,0.154,0.1497,-0.127,0.4249,0.1458,-1.5917,-159.2,间接影响（中介效应）,强,正向中介,正向直接效应,完全中介,0.9385,否,0.9385,0.0615,该路径的中介效应不显著。 中介效应强度为完全中介，中介比例为-159.2%。
61,检验_氯 → 检验_葡萄糖 → 疾病_混合痔,0.0534,-0.0624,0.1618,0.0576,-0.1704,-0.4342,0.1061,0.1452,-0.1171,-0.4101,0.1741,0.1546,6.8394,683.9,直接影响,强,正向中介,负向直接效应,完全中介,0.8485,否,0.8485,0.1515,该路径的中介效应不显著。 中介效应强度为完全中介，中介比例为683.9%。
62,检验_氯 → 检验_葡萄糖 → 疾病_糖尿病,-0.0734,-0.226,0.0587,0.0755,0.0468,-0.2335,0.2791,0.1316,-0.0266,-0.3013,0.2548,0.1505,-0.2836,-28.4,间接影响（中介效应）,强,负向中介,正向直接效应,部分中介,0.8525,否,0.1475,0.8525,该路径的中介效应不显著。 中介效应强度为部分中介，中介比例为-28.4%。
63,检验_氯 → 检验_葡萄糖 → 疾病_冠状动脉粥样硬化性心脏病,0.0298,-0.0347,0.1223,0.0417,0.0039,-0.2687,0.2838,0.1459,0.0337,-0.2435,0.3173,0.1493,-0.4692,-46.9,间接影响（中介效应）,强,正向中介,正向直接效应,部分中介,0.7925,否,0.7925,0.2075,该路径的中介效应不显著。 中介效应强度为部分中介，中介比例为-46.9%。
64,检验_氯 → 药物_肝素钠注射液 → 药物_氯化钠注射液,0.1234,-0.004,0.2498,0.0705,0.0872,-0.1996,0.3458,0.1439,0.2106,-0.0608,0.4919,0.1478,0.8238,82.4,间接影响（中介效应）,强,正向中介,正向直接效应,完全中介,0.985,是,0.985,0.015,该路径存在显著的正向中介，主要通过间接影响发挥作用。 中介效应强度为完全中介，中介比例为82.4%。
65,检验_总蛋白 → 疾病_动脉硬化 → 疾病_脂肪肝,0.0372,-0.0954,0.183,0.0757,-0.0055,-0.2396,0.2551,0.1313,0.0317,-0.2536,0.3086,0.1496,0.6912,69.1,间接影响（中介效应）,强,正向中介,负向直接效应,部分中介,0.6935,否,0.6935,0.3065,该路径的中介效应不显著。 中介效应强度为部分中介，中介比例为69.1%。
66,检验_总蛋白 → 疾病_高血压 → 检验_钾,0.1261,-0.0123,0.268,0.0771,0.069,-0.2222,0.3459,0.1531,0.195,-0.0813,0.4667,0.1445,-0.187,-18.7,间接影响（中介效应）,强,正向中介,正向直接效应,弱中介,0.9745,是,0.9745,0.0255,该路径存在显著的正向中介，主要通过间接影响发挥作用。 中介效应强度为弱中介，中介比例为-18.7%。
67,检验_总蛋白 → 疾病_高血压 → 药物_阿司匹林肠溶片,0.0532,-0.0742,0.2048,0.0708,-0.1933,-0.4769,0.1203,0.1602,-0.14,-0.4226,0.1327,0.1442,-0.1412,-14.1,直接影响,强,正向中介,负向直接效应,弱中介,0.7945,否,0.7945,0.2055,该路径的中介效应不显著。 中介效应强度为弱中介，中介比例为-14.1%。
68,检验_总蛋白 → 疾病_高血压 → 检验_碳酸氢盐,0.1251,-0.0126,0.2634,0.0774,-0.2143,-0.4937,0.083,0.1545,-0.0892,-0.3524,0.196,0.1465,0.1823,18.2,直接影响,强,正向中介,负向直接效应,弱中介,0.9715,是,0.9715,0.0285,该路径存在显著的负向直接效应，主要通过直接影响发挥作用。 中介效应强度为弱中介，中介比例为18.2%。
69,检验_总蛋白 → 疾病_高血压 → 药物_阿卡波糖片,0.1649,0.0214,0.3249,0.0828,-0.0321,-0.3178,0.2611,0.1531,0.1329,-0.1476,0.4202,0.1501,-0.2131,-21.3,间接影响（中介效应）,强,正向中介,负向直接效应,部分中介,0.9945,是,0.9945,0.0055,该路径存在显著的正向中介，主要通过间接影响发挥作用。 中介效应强度为部分中介，中介比例为-21.3%。
70,检验_总蛋白 → 疾病_高血压 → 药物_碳酸钙片,0.0532,-0.0743,0.2048,0.0709,-0.1886,-0.4708,0.1267,0.1603,-0.1354,-0.4181,0.1375,0.1442,-0.4114,-41.1,直接影响,强,正向中介,负向直接效应,部分中介,0.7945,否,0.7945,0.2055,该路径的中介效应不显著。 中介效应强度为部分中介，中介比例为-41.1%。
71,检验_总蛋白 → 疾病_高血压 → 药物_苯磺酸氨氯地平片,0.0717,-0.0517,0.2023,0.0684,0.2359,-0.0642,0.5148,0.1558,0.3075,0.0304,0.5566,0.1415,0.2945,29.4,直接影响,强,正向中介,正向直接效应,部分中介,0.8745,否,0.8745,0.1255,该路径的中介效应不显著。 中介效应强度为部分中介，中介比例为29.4%。
72,检验_总蛋白 → 检验_氯 → 检验_钠,0.1408,0.0103,0.2935,0.0789,-0.1882,-0.4482,0.0905,0.1421,-0.0474,-0.3155,0.2221,0.1467,0.086,8.6,直接影响,强,正向中介,负向直接效应,弱中介,0.986,是,0.986,0.014,该路径存在显著的负向直接效应，主要通过直接影响发挥作用。 中介效应强度为弱中介，中介比例为8.6%。
73,检验_总蛋白 → 检验_氯 → 检验_葡萄糖,-0.0579,-0.1773,0.0297,0.0554,0.1309,-0.1522,0.4119,0.1499,0.073,-0.2139,0.3314,0.1438,-0.4433,-44.3,直接影响,强,负向中介,正向直接效应,部分中介,0.887,否,0.113,0.887,该路径的中介效应不显著。 中介效应强度为部分中介，中介比例为-44.3%。
74,检验_总蛋白 → 检验_氯 → 药物_肝素钠注射液,0.0869,-0.01,0.214,0.0617,0.1169,-0.1554,0.3985,0.1475,0.2038,-0.045,0.489,0.1452,-0.4791,-47.9,直接影响,强,正向中介,正向直接效应,部分中介,0.96,是,0.96,0.04,该路径存在显著的正向直接效应，主要通过直接影响发挥作用。 中介效应强度为部分中介，中介比例为-47.9%。
75,检验_碳酸氢盐 → 检验_总蛋白 → 疾病_动脉硬化,-0.0063,-0.0565,0.0396,0.0253,0.1125,-0.1576,0.4154,0.1508,0.1062,-0.1884,0.3794,0.1508,0.1467,14.7,直接影响,强,负向中介,正向直接效应,弱中介,0.6,否,0.4,0.6,该路径的中介效应不显著。 中介效应强度为弱中介，中介比例为14.7%。
76,检验_碳酸氢盐 → 检验_总蛋白 → 药物_苯磺酸氨氯地平片,-0.025,-0.1231,0.0545,0.0468,-0.0933,-0.36,0.1727,0.1402,-0.1183,-0.4047,0.1512,0.1464,-0.0323,-3.2,直接影响,强,负向中介,负向直接效应,弱中介,0.729,否,0.271,0.729,该路径的中介效应不显著。 中介效应强度为弱中介，中介比例为-3.2%。
77,检验_碳酸氢盐 → 检验_总蛋白 → 疾病_高血压,-0.0399,-0.1677,0.072,0.0648,0.2492,-0.0116,0.4937,0.1341,0.2094,-0.0704,0.4838,0.1477,-0.6402,-64.0,直接影响,强,负向中介,正向直接效应,部分中介,0.743,否,0.257,0.743,该路径的中介效应不显著。 中介效应强度为部分中介，中介比例为-64.0%。
78,检验_碳酸氢盐 → 检验_总蛋白 → 检验_氯,-0.0262,-0.1231,0.067,0.0504,0.2611,-0.011,0.5182,0.1375,0.2349,-0.0411,0.5082,0.146,0.1393,13.9,直接影响,强,负向中介,正向直接效应,弱中介,0.7115,否,0.2885,0.7115,该路径的中介效应不显著。 中介效应强度为弱中介，中介比例为13.9%。
79,检验_碳酸氢盐 → 检验_尿酸 → 检验_镁,0.1045,-0.0031,0.24,0.068,0.1301,-0.1293,0.4158,0.1467,0.2347,-0.0215,0.5133,0.1448,-0.1109,-11.1,直接影响,强,正向中介,正向直接效应,弱中介,0.974,是,0.974,0.026,该路径存在显著的正向直接效应，主要通过直接影响发挥作用。 中介效应强度为弱中介，中介比例为-11.1%。
80,检验_碳酸氢盐 → 检验_尿酸 → 检验_磷,0.1512,0.0084,0.2956,0.081,-0.2965,-0.5672,-0.033,0.1406,-0.1453,-0.4198,0.1203,0.1447,-0.4553,-45.5,直接影响,强,正向中介,负向直接效应,部分中介,0.99,是,0.99,0.01,该路径存在显著的负向直接效应，主要通过直接影响发挥作用。 中介效应强度为部分中介，中介比例为-45.5%。
81,检验_碳酸氢盐 → 检验_尿酸 → 药物_硫酸氢氯吡格雷片,0.0913,-0.021,0.2193,0.0663,0.0197,-0.2721,0.3104,0.1566,0.111,-0.1546,0.4024,0.1519,-9.0814,-908.1,间接影响（中介效应）,强,正向中介,正向直接效应,完全中介,0.952,是,0.952,0.048,该路径存在显著的正向中介，主要通过间接影响发挥作用。 中介效应强度为完全中介，中介比例为-908.1%。
82,检验_碳酸氢盐 → 检验_尿酸 → 疾病_混合痔,-0.1229,-0.2556,0.0017,0.072,-0.1011,-0.3566,0.1764,0.1458,-0.224,-0.5109,0.0371,0.1453,0.5158,51.6,间接影响（中介效应）,强,负向中介,负向直接效应,部分中介,0.9855,是,0.0145,0.9855,该路径存在显著的负向中介，主要通过间接影响发挥作用。 中介效应强度为部分中介，中介比例为51.6%。
83,检验_碳酸氢盐 → 检验_磷 → 药物_碳酸钙片,-0.0589,-0.1812,0.0519,0.0634,0.1728,-0.0838,0.4287,0.1397,0.1138,-0.1701,0.3843,0.1492,-1.4913,-149.1,直接影响,强,负向中介,正向直接效应,完全中介,0.8565,否,0.1435,0.8565,该路径的中介效应不显著。 中介效应强度为完全中介，中介比例为-149.1%。
84,药物_阿卡波糖片 → 疾病_高血压 → 检验_总蛋白,0.1647,0.018,0.3087,0.0834,-0.0357,-0.2995,0.2347,0.145,0.129,-0.1346,0.4231,0.1483,2.1817,218.2,间接影响（中介效应）,强,正向中介,负向直接效应,完全中介,0.995,是,0.995,0.005,该路径存在显著的正向中介，主要通过间接影响发挥作用。 中介效应强度为完全中介，中介比例为218.2%。
85,药物_阿卡波糖片 → 疾病_高血压 → 检验_钾,0.1106,-0.0087,0.247,0.0711,0.1171,-0.1541,0.4145,0.1489,0.2277,-0.0257,0.5063,0.1406,0.0279,2.8,直接影响,强,正向中介,正向直接效应,弱中介,0.9655,是,0.9655,0.0345,该路径存在显著的正向直接效应，主要通过直接影响发挥作用。 中介效应强度为弱中介，中介比例为2.8%。
86,药物_阿卡波糖片 → 疾病_高血压 → 药物_阿司匹林肠溶片,-0.0264,-0.1575,0.0889,0.0637,0.3268,0.0381,0.6038,0.153,0.3004,0.0376,0.5597,0.1417,-0.2105,-21.0,直接影响,强,负向中介,正向直接效应,部分中介,0.6795,否,0.3205,0.6795,该路径的中介效应不显著。 中介效应强度为部分中介，中介比例为-21.0%。
87,药物_阿卡波糖片 → 疾病_高血压 → 检验_碳酸氢盐,0.0994,-0.0307,0.2352,0.0716,-0.1068,-0.422,0.1753,0.1605,-0.0073,-0.3009,0.2549,0.1493,-0.0663,-6.6,直接影响,强,正向中介,负向直接效应,弱中介,0.944,否,0.944,0.056,该路径的中介效应不显著。 中介效应强度为弱中介，中介比例为-6.6%。
88,药物_阿卡波糖片 → 疾病_高血压 → 药物_碳酸钙片,0.0352,-0.0874,0.1612,0.0637,-0.092,-0.3819,0.2127,0.1597,-0.0568,-0.3365,0.216,0.1505,5.7721,577.2,直接影响,强,正向中介,负向直接效应,完全中介,0.727,否,0.727,0.273,该路径的中介效应不显著。 中介效应强度为完全中介，中介比例为577.2%。
89,药物_阿卡波糖片 → 疾病_高血压 → 药物_苯磺酸氨氯地平片,0.1291,-0.0055,0.2747,0.0765,-0.1872,-0.4696,0.1199,0.1563,-0.0581,-0.3423,0.2129,0.149,-1.1342,-113.4,直接影响,强,正向中介,负向直接效应,完全中介,0.98,是,0.98,0.02,该路径存在显著的负向直接效应，主要通过直接影响发挥作用。 中介效应强度为完全中介，中介比例为-113.4%。
90,疾病_混合痔 → 疾病_高脂血症 → 疾病_反流性食管炎,-0.1349,-0.2686,-0.0112,0.0731,-0.1411,-0.387,0.1327,0.1379,-0.276,-0.5282,-0.0212,0.1377,0.5978,59.8,直接影响,强,负向中介,负向直接效应,部分中介,0.9905,是,0.0095,0.9905,该路径存在显著的负向直接效应，主要通过直接影响发挥作用。 中介效应强度为部分中介，中介比例为59.8%。
91,疾病_混合痔 → 疾病_高脂血症 → 药物_阿托伐他汀钙片,-0.1663,-0.3293,-0.0358,0.0806,-0.0581,-0.3115,0.203,0.1365,-0.2243,-0.5078,0.0337,0.1434,1.2532,125.3,间接影响（中介效应）,强,负向中介,负向直接效应,完全中介,0.996,是,0.004,0.996,该路径存在显著的负向中介，主要通过间接影响发挥作用。 中介效应强度为完全中介，中介比例为125.3%。
92,疾病_混合痔 → 疾病_高脂血症 → 疾病_动脉硬化,-0.1387,-0.2742,0.0029,0.0769,-0.1032,-0.371,0.1526,0.1419,-0.2419,-0.5008,0.0448,0.1448,0.1872,18.7,间接影响（中介效应）,强,负向中介,负向直接效应,弱中介,0.991,是,0.009,0.991,该路径存在显著的负向中介，主要通过间接影响发挥作用。 中介效应强度为弱中介，中介比例为18.7%。
93,疾病_混合痔 → 疾病_高脂血症 → 药物_阿司匹林肠溶片,-0.062,-0.187,0.0343,0.0599,-0.1631,-0.4764,0.0998,0.1524,-0.2252,-0.5051,0.0388,0.1453,0.3596,36.0,直接影响,强,负向中介,负向直接效应,部分中介,0.8755,否,0.1245,0.8755,该路径的中介效应不显著。 中介效应强度为部分中介，中介比例为36.0%。
94,疾病_混合痔 → 检验_尿酸 → 检验_碳酸氢盐,-0.1157,-0.2587,0.0034,0.0716,-0.1026,-0.3858,0.1777,0.1486,-0.2183,-0.4933,0.06,0.1459,0.5721,57.2,间接影响（中介效应）,强,负向中介,负向直接效应,部分中介,0.975,是,0.025,0.975,该路径存在显著的负向中介，主要通过间接影响发挥作用。 中介效应强度为部分中介，中介比例为57.2%。
95,疾病_混合痔 → 检验_尿酸 → 检验_镁,-0.1348,-0.286,-0.0141,0.0755,-0.0028,-0.2818,0.2762,0.1511,-0.1376,-0.4223,0.137,0.1486,1.8076,180.8,间接影响（中介效应）,强,负向中介,负向直接效应,完全中介,0.9855,是,0.0145,0.9855,该路径存在显著的负向中介，主要通过间接影响发挥作用。 中介效应强度为完全中介，中介比例为180.8%。
96,疾病_混合痔 → 检验_尿酸 → 检验_磷,-0.1348,-0.286,-0.0141,0.0755,-0.0028,-0.2818,0.2762,0.1511,-0.1376,-0.4223,0.137,0.1486,1.8076,180.8,间接影响（中介效应）,强,负向中介,负向直接效应,完全中介,0.9855,是,0.0145,0.9855,该路径存在显著的负向中介，主要通过间接影响发挥作用。 中介效应强度为完全中介，中介比例为180.8%。
97,疾病_混合痔 → 检验_尿酸 → 药物_硫酸氢氯吡格雷片,-0.1075,-0.2472,0.0134,0.0729,-0.0073,-0.299,0.2667,0.1516,-0.1148,-0.3736,0.1678,0.1458,-0.1462,-14.6,间接影响（中介效应）,强,负向中介,负向直接效应,弱中介,0.9645,是,0.0355,0.9645,该路径存在显著的负向中介，主要通过间接影响发挥作用。 中介效应强度为弱中介，中介比例为-14.6%。
98,疾病_混合痔 → 检验_葡萄糖 → 疾病_糖尿病,-0.1631,-0.2986,-0.0181,0.0794,-0.0843,-0.3341,0.1782,0.1366,-0.2474,-0.5176,0.0277,0.1459,0.6823,68.2,间接影响（中介效应）,强,负向中介,负向直接效应,部分中介,0.9945,是,0.0055,0.9945,该路径存在显著的负向中介，主要通过间接影响发挥作用。 中介效应强度为部分中介，中介比例为68.2%。
99,疾病_混合痔 → 检验_葡萄糖 → 疾病_冠状动脉粥样硬化性心脏病,0.0837,-0.0223,0.2089,0.0637,-0.1162,-0.3959,0.1789,0.1533,-0.0326,-0.3177,0.2441,0.1477,-0.7167,-71.7,直接影响,强,正向中介,负向直接效应,部分中介,0.9405,否,0.9405,0.0595,该路径的中介效应不显著。 中介效应强度为部分中介，中介比例为-71.7%。
100,检验_葡萄糖 → 疾病_混合痔 → 疾病_高脂血症,0.1188,0.0077,0.2604,0.0704,0.0539,-0.2554,0.2953,0.1459,0.1727,-0.1058,0.4522,0.1476,0.9805,98.0,间接影响（中介效应）,强,正向中介,正向直接效应,完全中介,0.9855,是,0.9855,0.0145,该路径存在显著的正向中介，主要通过间接影响发挥作用。 中介效应强度为完全中介，中介比例为98.0%。
101,检验_葡萄糖 → 疾病_混合痔 → 检验_尿酸,0.1277,0.0087,0.2675,0.0738,0.085,-0.1715,0.3776,0.1445,0.2127,-0.0541,0.5133,0.1491,0.751,75.1,间接影响（中介效应）,强,正向中介,正向直接效应,部分中介,0.99,是,0.99,0.01,该路径存在显著的正向中介，主要通过间接影响发挥作用。 中介效应强度为部分中介，中介比例为75.1%。
102,检验_葡萄糖 → 疾病_糖尿病 → 疾病_高尿酸血症,0.2397,0.0765,0.425,0.0951,-0.0607,-0.3409,0.2243,0.1536,0.179,-0.0752,0.4647,0.1446,0.3272,32.7,间接影响（中介效应）,强,正向中介,负向直接效应,部分中介,0.999,是,0.999,0.001,该路径存在显著的正向中介，主要通过间接影响发挥作用。 中介效应强度为部分中介，中介比例为32.7%。
103,检验_葡萄糖 → 疾病_糖尿病 → 药物_盐酸羟考酮缓释片,0.18,0.0152,0.3529,0.0914,-0.0799,-0.379,0.2256,0.1608,0.1,-0.164,0.3815,0.1466,-3.2814,-328.1,间接影响（中介效应）,强,正向中介,负向直接效应,完全中介,0.987,是,0.987,0.013,该路径存在显著的正向中介，主要通过间接影响发挥作用。 中介效应强度为完全中介，中介比例为-328.1%。
104,检验_葡萄糖 → 疾病_糖尿病 → 药物_阿卡波糖片,0.2095,0.0407,0.3846,0.0908,0.0964,-0.2005,0.3752,0.1508,0.3059,0.0383,0.5678,0.1385,0.9404,94.0,间接影响（中介效应）,强,正向中介,正向直接效应,完全中介,0.999,是,0.999,0.001,该路径存在显著的正向中介，主要通过间接影响发挥作用。 中介效应强度为完全中介，中介比例为94.0%。
105,检验_葡萄糖 → 疾病_糖尿病 → 药物_阿司匹林肠溶片,0.2111,0.0538,0.3769,0.0899,0.177,-0.0818,0.4727,0.1454,0.3881,0.1406,0.6555,0.1362,0.8121,81.2,间接影响（中介效应）,强,正向中介,正向直接效应,完全中介,0.9985,是,0.9985,0.0015,该路径存在显著的正向中介，主要通过间接影响发挥作用。 中介效应强度为完全中介，中介比例为81.2%。
106,药物_阿司匹林肠溶片 → 疾病_糖尿病 → 疾病_高尿酸血症,0.1771,0.0265,0.3566,0.0894,0.1997,-0.0839,0.511,0.1558,0.3767,0.1324,0.6548,0.1385,0.4935,49.3,直接影响,强,正向中介,正向直接效应,部分中介,0.9865,是,0.9865,0.0135,该路径存在显著的正向直接效应，主要通过直接影响发挥作用。 中介效应强度为部分中介，中介比例为49.3%。
107,药物_阿司匹林肠溶片 → 疾病_糖尿病 → 药物_盐酸羟考酮缓释片,0.2523,0.0662,0.4457,0.103,-0.3318,-0.6487,-0.0431,0.1576,-0.0795,-0.352,0.2094,0.1482,-0.1501,-15.0,直接影响,强,正向中介,负向直接效应,弱中介,0.998,是,0.998,0.002,该路径存在显著的负向直接效应，主要通过直接影响发挥作用。 中介效应强度为弱中介，中介比例为-15.0%。
108,药物_阿司匹林肠溶片 → 疾病_糖尿病 → 药物_阿卡波糖片,0.2161,0.0521,0.4096,0.0966,0.0867,-0.1847,0.3866,0.1495,0.3028,0.0599,0.5768,0.14,1.242,124.2,间接影响（中介效应）,强,正向中介,正向直接效应,完全中介,0.995,是,0.995,0.005,该路径存在显著的正向中介，主要通过间接影响发挥作用。 中介效应强度为完全中介，中介比例为124.2%。
109,药物_阿司匹林肠溶片 → 疾病_糖尿病 → 检验_葡萄糖,0.2081,0.0508,0.379,0.0897,0.1751,-0.0962,0.4445,0.1469,0.3832,0.1156,0.6265,0.1357,0.6127,61.3,间接影响（中介效应）,强,正向中介,正向直接效应,部分中介,0.9965,是,0.9965,0.0035,该路径存在显著的正向中介，主要通过间接影响发挥作用。 中介效应强度为部分中介，中介比例为61.3%。
110,药物_氯化钠注射液 → 检验_谷草/谷丙 → 检验_钾,-0.0226,-0.1046,0.0363,0.0379,-0.0543,-0.34,0.2118,0.1474,-0.0768,-0.3769,0.1915,0.1517,0.2772,27.7,直接影响,强,负向中介,负向直接效应,部分中介,0.746,否,0.254,0.746,该路径的中介效应不显著。 中介效应强度为部分中介，中介比例为27.7%。
111,药物_氯化钠注射液 → 检验_谷草/谷丙 → 药物_艾司唑仑片,-0.005,-0.0636,0.0478,0.0279,-0.1107,-0.3867,0.1583,0.1479,-0.1157,-0.3889,0.1661,0.1487,-0.2521,-25.2,直接影响,强,负向中介,负向直接效应,部分中介,0.591,否,0.409,0.591,该路径的中介效应不显著。 中介效应强度为部分中介，中介比例为-25.2%。
112,药物_氯化钠注射液 → 检验_谷草/谷丙 → 疾病_糖尿病,0.0249,-0.042,0.1073,0.0398,-0.2305,-0.4854,0.0357,0.142,-0.2056,-0.4888,0.0628,0.1465,0.0109,1.1,直接影响,强,正向中介,负向直接效应,弱中介,0.7435,否,0.7435,0.2565,该路径的中介效应不显著。 中介效应强度为弱中介，中介比例为1.1%。
113,药物_氯化钠注射液 → 检验_谷草/谷丙 → 药物_硫酸氢氯吡格雷片,0.0295,-0.0477,0.114,0.0429,-0.0941,-0.371,0.1675,0.1467,-0.0646,-0.3436,0.214,0.1511,-0.6496,-65.0,直接影响,强,正向中介,负向直接效应,部分中介,0.7755,否,0.7755,0.2245,该路径的中介效应不显著。 中介效应强度为部分中介，中介比例为-65.0%。
114,药物_肝素钠注射液 → 药物_氯化钠注射液 → 检验_谷草/谷丙,-0.089,-0.2292,0.042,0.0722,0.2036,-0.1127,0.4731,0.159,0.1147,-0.153,0.3877,0.1492,0.3432,34.3,直接影响,强,负向中介,正向直接效应,部分中介,0.9145,否,0.0855,0.9145,该路径的中介效应不显著。 中介效应强度为部分中介，中介比例为34.3%。
